Christian Toso

Molecular detection of circulating beta-cells after islet transplantation.

Human islet retransplantation in a patient with type I diabetes.

FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.

Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation.

Potential impact of in situ liver splitting on the number of available grafts.

Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.

Hepatocellular adenoma and polycystic ovary syndrome.

Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient.

Intra-portal injection of 400- microm microcapsules in a large-animal model.

Acquired and reversible Pelger-Huët anomaly of polymorphonuclear neutrophils in three transplant patients receiving mycophenolate mofetil therapy.

Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.

Activation of human macrophages by allogeneic islets preparations: inhibition by AOP-RANTES and heparinoids.

Are criteria for islet and pancreas donors sufficiently different to minimize competition?

Positron-emission tomography imaging of early events after transplantation of islets of Langerhans.

Intussusception as a cause of bowel obstruction in adults.

Macrophage depletion prolongs discordant but not concordant islet xenograft survival.

Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.

Microbial surveillance during human pancreatic islet isolation.

Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation.

Effect of microcapsule composition and short-term immunosuppression on intraportal biocompatibility.

Islet transplantation in a recipient presenting the factor V Leiden mutation.

Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells.

Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.

Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.

Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors.

Does mycophenolate mofetil reduce the risk of late acute rejection after liver transplantation?

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

ABO-incompatible liver transplantation for critically ill adult patients.

Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome.

The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation.

In vivo study of HCV in mice with chimeric human livers.

The role of macrophage migration inhibitory factor in mouse islet transplantation.

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.

Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria.

Costimulatory blockade with belatacept in clinical and experimental transplantation - a review.

Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation.

Are stem cells a cure for diabetes?

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture.

Histologic graft assessment after clinical islet transplantation.

The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation.

Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management.

Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.

Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success.

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

Role of imaging in clinical islet transplantation.

Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.

The place of downstaging for hepatocellular carcinoma.

Calcifying bowel inflammation: a case report.

Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.

Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model.

Assessment of human islet labeling with clinical grade iron nanoparticles prior to transplantation for graft monitoring by MRI.

Splenic rupture after colonoscopy.

Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology?

Detecting rejection after mouse Islet transplantation utilizing islet protein-stimulated ELISPOT.

Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events.

The impact of sirolimus on hepatitis C recurrence after liver transplantation.

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

Influence of donor age on islet isolation and transplantation outcome.

Liver mass with central calcification.

Appendectomy during the third trimester of pregnancy in a 27-year old patient: case report of a "near miss" complication.

Which matters most: number of tumors, size of the largest tumor, or total tumor volume?

The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice.

Demographics and outcomes of severe herpes simplex virus hepatitis: a registry-based study.

Complications of elective liver resections in a center with low mortality: a simple score to predict morbidity.

Noninvasive imaging techniques in islet transplantation.

Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.

AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient mice.

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis.

A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.

Herpes simplex virus load to monitor antiviral treatment after liver transplantation for acute herpetic hepatitis.

Adult hepatoblastoma: learning from children.

Management of a ruptured hydatid cyst involving the ribs: Dealing with a challenging case and review of the literature.

Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.

Three-dimensional laparoscopy: a step toward advanced surgical navigation.

Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring.

A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.

Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit.

Donor hypernatremia influences outcomes following pediatric liver transplantation.

The impact of wait list body mass index changes on the outcome after liver transplantation.

Image of the month. Abscess due to a "lost" stone during the previous cholecystectomy.

International workshop: islet transplantation without borders enabling islet transplantation in Greece with international collaboration and innovative technology.

Systematic review and meta-analysis of fibrin sealants for patients undergoing pancreatic resection.

NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry.

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence.